An Epidemic Zika Virus Isolate Drives Enhanced T Follicular Helper Cell and B Cell-Mediated Immunity.
Ryan D PardyMaria E GentileAlexandria M CarterStephanie A CondottaIrah L KingMartin J RicherPublished in: Journal of immunology (Baltimore, Md. : 1950) (2022)
Zika virus (ZIKV) is a mosquito-borne pathogen that recently caused a series of increasingly severe outbreaks. We previously demonstrated that, compared with a pre-epidemic isolate (ZIKV CDN ), a Brazilian ZIKV isolate (ZIKV BR ) possesses a novel capacity to suppress host immunity, resulting in delayed viral clearance. However, whether ZIKV BR modulates CD4 T cell responses remains unknown. In this study, we show that, in comparison with ZIKV CDN infection, CD4 T cells are less polarized to the Th1 subtype following ZIKV BR challenge in mice. In contrast, we observed an enhanced accumulation of T follicular helper cells 10, 14, and 21 d postinfection with ZIKV BR This response correlated with an enhanced germinal center B cell response and robust production of higher avidity-neutralizing Abs following ZIKV BR infection. Taken together, our data suggest that contemporary ZIKV strains have evolved to differentially induce CD4 T cell, B cell, and Ab responses and this could provide a model to further define the signals required for T follicular helper cell development.
Keyphrases
- zika virus
- dengue virus
- aedes aegypti
- regulatory t cells
- dendritic cells
- single cell
- magnetic resonance imaging
- magnetic resonance
- stem cells
- computed tomography
- machine learning
- type diabetes
- metabolic syndrome
- deep learning
- early onset
- cell therapy
- candida albicans
- adipose tissue
- electronic health record
- immune response
- data analysis
- drug induced
- big data
- insulin resistance